Old Web
English
Sign In
Acemap
>
authorDetail
>
David W. Cushman
David W. Cushman
Bristol-Myers Squibb
Chemistry
Biochemistry
Phosphonate
Proline
Organic chemistry
4
Papers
115
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Inhibiteurs quinazolinone de la phosphodiesterase cgmp
1999
John E. Macor
David P. Rotella
Harold N. Weller
David W. Cushman
Joseph P Yevich
Show All
Source
Cite
Save
Citations (0)
Quinazolinonehemmendern von cgmp phosphodiesterase
1999
John E. Macor
David P. Rotella
Harold N. Weller
David W. Cushman
Joseph P Yevich
Show All
Source
Cite
Save
Citations (0)
(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme. 2. Terminal amino acid analogues of (S)-1-[6-amino-2 [[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline.
1990
Journal of Medicinal Chemistry
Donald S. Karanewsky
Michael Badia
David W. Cushman
Jack M. DeForrest
Tamara Dejneka
Ving G. Lee
Melanie J. Loots
Edward W. Petrillo
Show All
Source
Cite
Save
Citations (20)
(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline, a novel orally active inhibitor of ACE
1988
Journal of Medicinal Chemistry
Donald S. Karanewsky
Michael Badia
David W. Cushman
Jack M. DeForrest
Tamara Dejneka
Melanie J. Loots
Maria G. Perri
Edward W. Petrillo
James R. Powell
Show All
Source
Cite
Save
Citations (95)
1